In 1984, Kaili Biotech was founded as a small biotechnology company. However, at the insistence of the founder, our company gradually grew. Today, Kaili has become a leader in the industry successfully.

Covering a total area of 581,175 square meters, our company now has a registered capital of CNY 30 million. After years of development, our company's total assets have reached CNY 560 million, and our own funds have exceeded CNY 290 million; therefore, our company now has very strong strength.

At present, Kaili Biotech has four branch plants and one sales department, with more than 280 employees, including over 35 professional technicians and 62 management personnel. All our employees are a strong support for the successful development of our company.

Adopting advanced technologies, our main business is to produce various alcohol products by decomposing and distilling fusel oil. And our products include butanol, 3-methyl-1-butanol, 1-propanol, mixed alcohols, 3-methylbutanol and 2-methylbutanol, etc. We annually can produce more than 20,000 tons of natural bio-based alcohol products, with an annual output value of up to CNY 360 million and an annual profits and taxes of CNY 110 million.

Relying on our innovative and unique technologies, Kaili Biotech has won a number of invention patents and honors of technology awards. These honors are the best recognition of our continuous efforts.

The market sales of our products have expanded to China, Southeast Asian, European and America, with a market share of more than 80% in the domestic market. Now, our products are in short supply, and the market prospect is unlimited.

The brilliant achievements of Kaili Biotech are inseparable from the joint efforts of all employees, who have always adhered to the pursuit of technology and the belief in quality. On the road of continuous innovation and development, they write success stories with their wisdom and diligence.

Looking back from today's height, Shandong Kaili Biotechnology Co., Ltd. has become a leading enterprise in the industry. Insisting to the concept of innovation and progress in the future, we are going to make greater contributions to the development of the biotechnology industry.